Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer.
Lorusso V, Crucitta E, Silvestris N, Catino A, Caporusso L, Mazzei A, Guida M, Latorre A, Sambiasi D, D'Amico C, Schittulli F, Calabrese P, De Lena M.
Lorusso V, et al.
Br J Cancer. 2003 Feb 24;88(4):491-5. doi: 10.1038/sj.bjc.6600780.
Br J Cancer. 2003.
PMID: 12592360
Free PMC article.
Clinical Trial.